ArticleJournal of hepatocellular carcinoma2026
The Survival Advantage of Prior Curative Hepatectomy in Patients with Hepatocellular Carcinoma Receiving First-Line Multikinase Inhibitors: A Propensity Score-Adjusted Study.
Jia-Min Wu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.